

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.05346626 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.93969763 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.93969763 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.93969763 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.93969763 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.93969763 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.93969763 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.36778663 |
| 9 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.08501434 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03554391 |
| 11 | positive regulation of heat generation (GO:0031652) | 4.82365500 |
| 12 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.80681278 |
| 13 | regulation of fever generation (GO:0031620) | 4.73892219 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.56805861 |
| 15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.38490885 |
| 16 | regulation of vitamin metabolic process (GO:0030656) | 4.35637986 |
| 17 | regulation of chemokine biosynthetic process (GO:0045073) | 4.23801803 |
| 18 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.20725355 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.19815036 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.18214657 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.12363043 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.01826199 |
| 23 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.00983319 |
| 24 | microglial cell activation (GO:0001774) | 4.00230190 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.99773717 |
| 26 | granulocyte activation (GO:0036230) | 3.95070762 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.94230070 |
| 28 | response to host immune response (GO:0052572) | 3.94230070 |
| 29 | respiratory burst (GO:0045730) | 3.90622098 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83600470 |
| 31 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.77912816 |
| 32 | superoxide anion generation (GO:0042554) | 3.77070712 |
| 33 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.74847411 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.69444650 |
| 35 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.69394988 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.68069681 |
| 37 | regulation of heat generation (GO:0031650) | 3.66402834 |
| 38 | glycosphingolipid catabolic process (GO:0046479) | 3.63869603 |
| 39 | leukocyte aggregation (GO:0070486) | 3.62842409 |
| 40 | negative regulation of interleukin-17 production (GO:0032700) | 3.62758992 |
| 41 | regulation of mononuclear cell migration (GO:0071675) | 3.62141894 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.57590083 |
| 43 | oligosaccharide catabolic process (GO:0009313) | 3.57522343 |
| 44 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.57304791 |
| 45 | neutrophil activation (GO:0042119) | 3.56232237 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.53918926 |
| 47 | response to host (GO:0075136) | 3.53918926 |
| 48 | response to host defenses (GO:0052200) | 3.53918926 |
| 49 | reactive oxygen species biosynthetic process (GO:1903409) | 3.52970988 |
| 50 | eosinophil chemotaxis (GO:0048245) | 3.52762875 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51011545 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.49215512 |
| 53 | germinal center formation (GO:0002467) | 3.48838528 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 3.48329752 |
| 55 | cellular extravasation (GO:0045123) | 3.43130846 |
| 56 | regulation of activation of Janus kinase activity (GO:0010533) | 3.42669700 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 3.41716779 |
| 58 | positive regulation of mast cell degranulation (GO:0043306) | 3.40687264 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.40687264 |
| 60 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.39708778 |
| 61 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.38442970 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.37680492 |
| 63 | macrophage activation (GO:0042116) | 3.36925877 |
| 64 | cellular response to interferon-beta (GO:0035458) | 3.36291210 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.35825965 |
| 66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.35285861 |
| 67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.33310358 |
| 68 | glycolipid catabolic process (GO:0019377) | 3.32793808 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.31562344 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.30451395 |
| 71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29640239 |
| 72 | positive regulation of interferon-beta production (GO:0032728) | 3.27610453 |
| 73 | regulation of interleukin-17 production (GO:0032660) | 3.26146352 |
| 74 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.25652063 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 3.25245535 |
| 76 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.24600085 |
| 77 | cellular response to exogenous dsRNA (GO:0071360) | 3.24439843 |
| 78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.23452885 |
| 79 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.21945988 |
| 80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21604758 |
| 81 | response to protozoan (GO:0001562) | 3.21248388 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21063921 |
| 83 | cellular response to lipopolysaccharide (GO:0071222) | 3.21024652 |
| 84 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.20784105 |
| 85 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.19537938 |
| 86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.18965482 |
| 87 | regulation of chronic inflammatory response (GO:0002676) | 3.17187087 |
| 88 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.16074158 |
| 89 | monocyte chemotaxis (GO:0002548) | 3.15125404 |
| 90 | eosinophil migration (GO:0072677) | 3.14650157 |
| 91 | cellular response to molecule of bacterial origin (GO:0071219) | 3.13653985 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.11595260 |
| 93 | positive regulation of interleukin-10 production (GO:0032733) | 3.11380782 |
| 94 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.10909777 |
| 95 | negative regulation of lipid storage (GO:0010888) | 3.10543950 |
| 96 | positive regulation of chemokine production (GO:0032722) | 3.10356673 |
| 97 | negative regulation of viral genome replication (GO:0045071) | 3.09908444 |
| 98 | type I interferon signaling pathway (GO:0060337) | 3.09280933 |
| 99 | cellular response to type I interferon (GO:0071357) | 3.09280933 |
| 100 | regulation of podosome assembly (GO:0071801) | 3.08668182 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07578813 |
| 102 | positive regulation of lymphocyte migration (GO:2000403) | 3.07154908 |
| 103 | regulation of interleukin-12 production (GO:0032655) | 3.06646873 |
| 104 | detection of other organism (GO:0098543) | 3.06236738 |
| 105 | response to type I interferon (GO:0034340) | 3.06073928 |
| 106 | myeloid dendritic cell activation (GO:0001773) | 3.06015564 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 3.03329788 |
| 108 | positive regulation of interleukin-6 production (GO:0032755) | 3.01979838 |
| 109 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00459037 |
| 110 | detection of external biotic stimulus (GO:0098581) | 2.99531932 |
| 111 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99238951 |
| 112 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.98462984 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.98034556 |
| 114 | cytokine secretion (GO:0050663) | 2.96618815 |
| 115 | positive regulation of humoral immune response (GO:0002922) | 2.95752239 |
| 116 | myeloid dendritic cell differentiation (GO:0043011) | 2.95675072 |
| 117 | neutrophil chemotaxis (GO:0030593) | 2.95341361 |
| 118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.95019212 |
| 119 | defense response to protozoan (GO:0042832) | 2.94736178 |
| 120 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.94541265 |
| 121 | leukocyte mediated cytotoxicity (GO:0001909) | 2.93655513 |
| 122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93169881 |
| 123 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.92483223 |
| 124 | positive regulation of acute inflammatory response (GO:0002675) | 2.92178766 |
| 125 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.92036422 |
| 126 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.91721564 |
| 127 | ceramide catabolic process (GO:0046514) | 2.91680140 |
| 128 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91567531 |
| 129 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.91189686 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.89876176 |
| 131 | amino sugar catabolic process (GO:0046348) | 2.85280220 |
| 132 | regulation of cholesterol storage (GO:0010885) | 2.84836152 |
| 133 | regulation of T cell tolerance induction (GO:0002664) | 2.83968744 |
| 134 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.82339648 |
| 135 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.81596988 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80070945 |
| 137 | regulation of type 2 immune response (GO:0002828) | 2.79236786 |
| 138 | regulation of antigen processing and presentation (GO:0002577) | 2.79008394 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77389851 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.77389851 |
| 141 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.74591411 |
| 142 | cellular response to biotic stimulus (GO:0071216) | 2.73017899 |
| 143 | B cell mediated immunity (GO:0019724) | 2.71290392 |
| 144 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.70233500 |
| 145 | cellular response to interferon-gamma (GO:0071346) | 2.68708297 |
| 146 | regulation of growth of symbiont in host (GO:0044126) | 2.68258165 |
| 147 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68258165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.85815249 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.87563613 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40645547 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.29357283 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.20725155 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.78441714 |
| 7 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72661315 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64193275 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63371576 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.53500733 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26545415 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17437090 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12672647 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09465416 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96025474 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72201436 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48665937 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41446145 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12800661 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.06388833 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04412286 |
| 22 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.87476719 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84859137 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84847753 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80171641 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.79068485 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78528318 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77000834 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65671165 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65299142 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64659047 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61832939 |
| 33 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57939671 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57799511 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57496213 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.45463847 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42336687 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42184159 |
| 39 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40895751 |
| 40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39368170 |
| 41 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.38876328 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37962393 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37868424 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33682593 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32274110 |
| 46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31800778 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30560474 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29360966 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27359746 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25890974 |
| 51 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24714093 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20888356 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20207595 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20142130 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14771354 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.14135977 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13500093 |
| 58 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11781038 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09619469 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07818031 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07212014 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07198645 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06773839 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06610182 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.05447557 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02184941 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02111116 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01840725 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00837104 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00754210 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99733743 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98868311 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98023412 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97505080 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97183059 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97183059 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94555560 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93874061 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 0.93390682 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93197140 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92813063 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92417215 |
| 83 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.91060902 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91021169 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90979461 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89167174 |
| 87 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89162521 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87360734 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87125463 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86679539 |
| 91 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84681770 |
| 92 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82410626 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81842761 |
| 94 | MYC_22102868_ChIP-Seq_BL_Human | 0.81276936 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80723789 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80261367 |
| 97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79869700 |
| 98 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.79701418 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79131874 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78931351 |
| 101 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78904430 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78673090 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78537762 |
| 104 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.78391368 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78004856 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76869100 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75915249 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75143342 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75143342 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72872268 |
| 111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70647567 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68499036 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.68441551 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67758046 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66264590 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.65577542 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.65328724 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.65112230 |
| 119 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.63247583 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61177053 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59751475 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59064349 |
| 123 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56642142 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56399130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.44719425 |
| 2 | MP0003436_decreased_susceptibility_to | 4.10025513 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.09635911 |
| 4 | MP0006082_CNS_inflammation | 3.94985238 |
| 5 | MP0003724_increased_susceptibility_to | 3.86716550 |
| 6 | * MP0002148_abnormal_hypersensitivity_rea | 3.64252548 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.48898438 |
| 8 | MP0002419_abnormal_innate_immunity | 3.42812851 |
| 9 | MP0003303_peritoneal_inflammation | 3.34045190 |
| 10 | MP0005025_abnormal_response_to | 3.11481080 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.66367320 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.61791650 |
| 13 | MP0005671_abnormal_response_to | 2.58937472 |
| 14 | MP0001790_abnormal_immune_system | 2.55827982 |
| 15 | MP0005387_immune_system_phenotype | 2.55827982 |
| 16 | * MP0002723_abnormal_immune_serum | 2.53714343 |
| 17 | MP0004510_myositis | 2.52354727 |
| 18 | MP0001800_abnormal_humoral_immune | 2.44372919 |
| 19 | MP0009764_decreased_sensitivity_to | 2.37504706 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.37277105 |
| 21 | MP0004947_skin_inflammation | 2.30126536 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.26085607 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.25378903 |
| 24 | MP0000685_abnormal_immune_system | 2.19900600 |
| 25 | * MP0001819_abnormal_immune_cell | 2.18741396 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.15637616 |
| 27 | MP0005451_abnormal_body_composition | 2.00603626 |
| 28 | MP0003075_altered_response_to | 1.98449134 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.97278927 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.95864563 |
| 31 | MP0000343_altered_response_to | 1.94563996 |
| 32 | MP0002006_tumorigenesis | 1.92248972 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.91315963 |
| 34 | MP0001853_heart_inflammation | 1.88965626 |
| 35 | MP0002405_respiratory_system_inflammati | 1.88040759 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.83992353 |
| 37 | MP0008469_abnormal_protein_level | 1.79228183 |
| 38 | MP0003448_altered_tumor_morphology | 1.77751886 |
| 39 | MP0009278_abnormal_bone_marrow | 1.74400265 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.60898276 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.59155341 |
| 42 | MP0006054_spinal_hemorrhage | 1.58623023 |
| 43 | MP0003828_pulmonary_edema | 1.55942800 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.55436106 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.54651586 |
| 46 | MP0005310_abnormal_salivary_gland | 1.49210864 |
| 47 | MP0000716_abnormal_immune_system | 1.47780542 |
| 48 | MP0005166_decreased_susceptibility_to | 1.45243979 |
| 49 | MP0000858_altered_metastatic_potential | 1.45223329 |
| 50 | MP0009840_abnormal_foam_cell | 1.41971297 |
| 51 | MP0003690_abnormal_glial_cell | 1.40838900 |
| 52 | MP0005164_abnormal_response_to | 1.35409821 |
| 53 | MP0002398_abnormal_bone_marrow | 1.32663264 |
| 54 | MP0002254_reproductive_system_inflammat | 1.20513772 |
| 55 | MP0000604_amyloidosis | 1.19712102 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.19155279 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.19155279 |
| 58 | MP0002429_abnormal_blood_cell | 1.15845561 |
| 59 | MP0002933_joint_inflammation | 1.14212428 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.13173303 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.12078970 |
| 62 | MP0005390_skeleton_phenotype | 1.10804310 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.09785180 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.09543826 |
| 65 | MP0001851_eye_inflammation | 1.06660184 |
| 66 | MP0009763_increased_sensitivity_to | 1.06542723 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.05590221 |
| 68 | MP0003186_abnormal_redox_activity | 1.04536296 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.02569383 |
| 70 | MP0008260_abnormal_autophagy | 1.00453099 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.97706927 |
| 72 | * MP0002722_abnormal_immune_system | 0.97057819 |
| 73 | MP0008004_abnormal_stomach_pH | 0.96722904 |
| 74 | MP0004883_abnormal_blood_vessel | 0.96677826 |
| 75 | MP0003195_calcinosis | 0.94279025 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.90961679 |
| 77 | MP0000249_abnormal_blood_vessel | 0.90900677 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.88785636 |
| 79 | MP0003329_amyloid_beta_deposits | 0.87985637 |
| 80 | MP0001663_abnormal_digestive_system | 0.81011782 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.79646877 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.78935624 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.77739405 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.77699498 |
| 85 | MP0001542_abnormal_bone_strength | 0.75085659 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.74172867 |
| 87 | MP0003646_muscle_fatigue | 0.74012952 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.73628257 |
| 89 | MP0000920_abnormal_myelination | 0.73246240 |
| 90 | MP0005165_increased_susceptibility_to | 0.71272430 |
| 91 | MP0008874_decreased_physiological_sensi | 0.68965545 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.68450840 |
| 93 | MP0005647_abnormal_sex_gland | 0.66303259 |
| 94 | MP0000371_diluted_coat_color | 0.66043295 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.65714489 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.65267330 |
| 97 | MP0003795_abnormal_bone_structure | 0.64907455 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.60911047 |
| 99 | MP0000609_abnormal_liver_physiology | 0.60865150 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.59609493 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.59392770 |
| 102 | MP0008873_increased_physiological_sensi | 0.57884299 |
| 103 | MP0010307_abnormal_tumor_latency | 0.57037001 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.56464821 |
| 105 | MP0003091_abnormal_cell_migration | 0.56276563 |
| 106 | MP0005535_abnormal_body_temperature | 0.54271951 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.52657831 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.52495565 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52121628 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.52068745 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.51879987 |
| 112 | MP0001873_stomach_inflammation | 0.51489191 |
| 113 | MP0004858_abnormal_nervous_system | 0.51156706 |
| 114 | MP0000490_abnormal_crypts_of | 0.50664901 |
| 115 | MP0005023_abnormal_wound_healing | 0.47460188 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.47395899 |
| 117 | MP0002090_abnormal_vision | 0.46920458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.12794529 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.29732547 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.19215721 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.61789339 |
| 5 | Stomatitis (HP:0010280) | 5.77740878 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.49614635 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.42634089 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.17935705 |
| 9 | Optic neuritis (HP:0100653) | 5.17935705 |
| 10 | Orchitis (HP:0100796) | 5.08039380 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78440478 |
| 12 | Myositis (HP:0100614) | 4.68421411 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.53213535 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.49730252 |
| 15 | Gingivitis (HP:0000230) | 4.41403064 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 4.28563896 |
| 17 | Recurrent skin infections (HP:0001581) | 4.25019404 |
| 18 | Loss of speech (HP:0002371) | 4.22437142 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 4.12685947 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.90934935 |
| 21 | Obstructive lung disease (HP:0006536) | 3.88144390 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.88144390 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.78926732 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.65909862 |
| 25 | Axonal loss (HP:0003447) | 3.58192041 |
| 26 | Vasculitis (HP:0002633) | 3.55873366 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.40910067 |
| 28 | Basal ganglia calcification (HP:0002135) | 3.31284309 |
| 29 | Mutism (HP:0002300) | 3.27133347 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.25914588 |
| 31 | Neurofibrillary tangles (HP:0002185) | 3.18088023 |
| 32 | Periodontitis (HP:0000704) | 3.10156674 |
| 33 | Disinhibition (HP:0000734) | 3.09720023 |
| 34 | Thick nail (HP:0001805) | 3.08222031 |
| 35 | Pustule (HP:0200039) | 3.05698369 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.03604725 |
| 37 | Cellulitis (HP:0100658) | 2.97726741 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.94757677 |
| 39 | Recurrent viral infections (HP:0004429) | 2.92248990 |
| 40 | Urticaria (HP:0001025) | 2.90448014 |
| 41 | Nuclear cataract (HP:0100018) | 2.89483174 |
| 42 | Nausea (HP:0002018) | 2.86969877 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83867633 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83867633 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83867633 |
| 46 | Prostate neoplasm (HP:0100787) | 2.78249086 |
| 47 | Glomerulonephritis (HP:0000099) | 2.77927166 |
| 48 | Increased serum ferritin (HP:0003281) | 2.76812439 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.75702364 |
| 50 | Apathy (HP:0000741) | 2.74778868 |
| 51 | Increased IgM level (HP:0003496) | 2.74286034 |
| 52 | Diminished motivation (HP:0000745) | 2.70826885 |
| 53 | Meningitis (HP:0001287) | 2.69313837 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66175242 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66175242 |
| 56 | Arterial thrombosis (HP:0004420) | 2.65268088 |
| 57 | Agnosia (HP:0010524) | 2.63846380 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.58804025 |
| 59 | Tetraparesis (HP:0002273) | 2.57186422 |
| 60 | Leukocytosis (HP:0001974) | 2.55419819 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.53975467 |
| 62 | Osteomyelitis (HP:0002754) | 2.53185145 |
| 63 | Hemoptysis (HP:0002105) | 2.52894850 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.51759280 |
| 65 | Petechiae (HP:0000967) | 2.41377400 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.40951773 |
| 67 | T lymphocytopenia (HP:0005403) | 2.38503716 |
| 68 | Myocardial infarction (HP:0001658) | 2.38468928 |
| 69 | Polyneuropathy (HP:0001271) | 2.38030988 |
| 70 | Hematochezia (HP:0002573) | 2.35965426 |
| 71 | Neuronal loss in central nervous system (HP:0002529) | 2.33606105 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.29920984 |
| 73 | Premature loss of primary teeth (HP:0006323) | 2.29492986 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.27341660 |
| 75 | Purpura (HP:0000979) | 2.27277997 |
| 76 | Inappropriate behavior (HP:0000719) | 2.25769024 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.24820616 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.23747424 |
| 79 | Bone pain (HP:0002653) | 2.22054239 |
| 80 | Encephalitis (HP:0002383) | 2.21574665 |
| 81 | Nephritis (HP:0000123) | 2.16547736 |
| 82 | Joint swelling (HP:0001386) | 2.15505496 |
| 83 | Episodic fever (HP:0001954) | 2.15079761 |
| 84 | Metaphyseal irregularity (HP:0003025) | 2.12922124 |
| 85 | Joint hemorrhage (HP:0005261) | 2.11202298 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.10830288 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10784446 |
| 88 | Amyloidosis (HP:0011034) | 2.10699011 |
| 89 | Gingival bleeding (HP:0000225) | 2.04542249 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.04266371 |
| 91 | Vertigo (HP:0002321) | 2.03091487 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02942714 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.02942714 |
| 94 | Arthralgia (HP:0002829) | 2.02748855 |
| 95 | Anorexia (HP:0002039) | 2.02742536 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01723580 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.01723580 |
| 98 | Progressive visual loss (HP:0000529) | 2.01201308 |
| 99 | Parakeratosis (HP:0001036) | 2.00873804 |
| 100 | Poor head control (HP:0002421) | 2.00472018 |
| 101 | Chronic otitis media (HP:0000389) | 1.99951398 |
| 102 | Colitis (HP:0002583) | 1.99276997 |
| 103 | Personality changes (HP:0000751) | 1.95176974 |
| 104 | Pathologic fracture (HP:0002756) | 1.92350670 |
| 105 | Vertebral compression fractures (HP:0002953) | 1.92037489 |
| 106 | Upper motor neuron abnormality (HP:0002127) | 1.91960146 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 1.91746415 |
| 108 | Porencephaly (HP:0002132) | 1.91581139 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91482057 |
| 110 | Gangrene (HP:0100758) | 1.91183488 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90348599 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90348599 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90348599 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.90049978 |
| 115 | Peripheral demyelination (HP:0011096) | 1.88047257 |
| 116 | Memory impairment (HP:0002354) | 1.85636526 |
| 117 | Glomerulopathy (HP:0100820) | 1.85597934 |
| 118 | Pulmonary embolism (HP:0002204) | 1.85556368 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 1.85328795 |
| 120 | Abnormality of the periventricular white matter (HP:0002518) | 1.83296090 |
| 121 | Dementia (HP:0000726) | 1.82840549 |
| 122 | Increased IgE level (HP:0003212) | 1.81994130 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.81849580 |
| 124 | Sepsis (HP:0100806) | 1.81111134 |
| 125 | Increased CSF protein (HP:0002922) | 1.80862243 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80814377 |
| 127 | Eosinophilia (HP:0001880) | 1.79104240 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.77246629 |
| 129 | Abnormality of the endocardium (HP:0004306) | 1.76898413 |
| 130 | Skin ulcer (HP:0200042) | 1.75594108 |
| 131 | Albinism (HP:0001022) | 1.74151824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.95366512 |
| 2 | IRAK3 | 4.42404684 |
| 3 | BLK | 4.39964778 |
| 4 | RIPK4 | 4.28928757 |
| 5 | TBK1 | 3.82143205 |
| 6 | IRAK4 | 3.19000933 |
| 7 | TXK | 3.18337492 |
| 8 | MAP4K1 | 3.01359075 |
| 9 | TAOK2 | 2.89740730 |
| 10 | IKBKE | 2.78842391 |
| 11 | IKBKB | 2.71235286 |
| 12 | TYK2 | 2.53272834 |
| 13 | PBK | 2.38205140 |
| 14 | DDR2 | 2.34225730 |
| 15 | JAK3 | 2.16331715 |
| 16 | PRPF4B | 2.11698114 |
| 17 | TAOK1 | 1.95740965 |
| 18 | KIT | 1.92047592 |
| 19 | JAK1 | 1.78172321 |
| 20 | CHUK | 1.75221388 |
| 21 | FGR | 1.71755123 |
| 22 | PIM2 | 1.70511655 |
| 23 | TGFBR2 | 1.63143994 |
| 24 | CSK | 1.53237488 |
| 25 | BMPR2 | 1.53172365 |
| 26 | MST4 | 1.46546750 |
| 27 | ERN1 | 1.46239558 |
| 28 | ZAP70 | 1.45440194 |
| 29 | BMX | 1.36707160 |
| 30 | SYK | 1.31533530 |
| 31 | ACVR1B | 1.29269771 |
| 32 | EPHB1 | 1.22346521 |
| 33 | CDC42BPA | 1.21070953 |
| 34 | LYN | 1.20639196 |
| 35 | MAP3K13 | 1.19394674 |
| 36 | HCK | 1.16705528 |
| 37 | CSF1R | 1.15171045 |
| 38 | TESK2 | 1.14662700 |
| 39 | PIM1 | 1.12609881 |
| 40 | EIF2AK2 | 1.12349016 |
| 41 | ABL2 | 1.11637399 |
| 42 | MATK | 1.04770874 |
| 43 | STK10 | 1.04621232 |
| 44 | MARK3 | 1.02804532 |
| 45 | GRK7 | 1.02431010 |
| 46 | JAK2 | 1.01208461 |
| 47 | LCK | 1.01132043 |
| 48 | NEK9 | 0.93042034 |
| 49 | RPS6KA4 | 0.92443906 |
| 50 | MST1R | 0.89104672 |
| 51 | BTK | 0.89007350 |
| 52 | MAP3K10 | 0.87564099 |
| 53 | PRKCD | 0.87099800 |
| 54 | IRAK1 | 0.85787883 |
| 55 | IRAK2 | 0.84006766 |
| 56 | TEC | 0.83856621 |
| 57 | FES | 0.78914484 |
| 58 | CLK1 | 0.78863534 |
| 59 | TAOK3 | 0.74551877 |
| 60 | MAP2K3 | 0.67283918 |
| 61 | ABL1 | 0.66096196 |
| 62 | EGFR | 0.66000587 |
| 63 | TRPM7 | 0.62754894 |
| 64 | YES1 | 0.62323675 |
| 65 | MAP3K5 | 0.61781053 |
| 66 | MAP3K12 | 0.61452880 |
| 67 | ITK | 0.59410354 |
| 68 | NME2 | 0.57004479 |
| 69 | BMPR1B | 0.56615166 |
| 70 | ERBB3 | 0.56482063 |
| 71 | TYRO3 | 0.55669311 |
| 72 | EPHA3 | 0.55661408 |
| 73 | DAPK2 | 0.55401563 |
| 74 | ERBB4 | 0.55064943 |
| 75 | ADRBK2 | 0.54635786 |
| 76 | FGFR3 | 0.52376387 |
| 77 | STK4 | 0.50593830 |
| 78 | DYRK3 | 0.50378551 |
| 79 | FGFR4 | 0.49514777 |
| 80 | STK24 | 0.45552886 |
| 81 | LRRK2 | 0.44881349 |
| 82 | TESK1 | 0.44040889 |
| 83 | PRKCQ | 0.43522880 |
| 84 | LATS2 | 0.43018770 |
| 85 | MOS | 0.42386708 |
| 86 | MAP3K3 | 0.41808942 |
| 87 | MAP2K6 | 0.41739331 |
| 88 | HIPK2 | 0.40404982 |
| 89 | ARAF | 0.40055336 |
| 90 | MAPKAPK2 | 0.37158082 |
| 91 | MAP3K1 | 0.36070941 |
| 92 | RPS6KC1 | 0.35512373 |
| 93 | RPS6KL1 | 0.35512373 |
| 94 | FYN | 0.34996464 |
| 95 | DAPK3 | 0.34985882 |
| 96 | SIK3 | 0.33847853 |
| 97 | PKN1 | 0.33540237 |
| 98 | ADRBK1 | 0.32395823 |
| 99 | MAPK7 | 0.30594410 |
| 100 | CAMKK2 | 0.30516901 |
| 101 | PAK4 | 0.29656405 |
| 102 | MAP3K11 | 0.28735478 |
| 103 | RIPK1 | 0.28025951 |
| 104 | PDK2 | 0.26981194 |
| 105 | IGF1R | 0.25932464 |
| 106 | PRKG2 | 0.24713272 |
| 107 | NLK | 0.23914616 |
| 108 | PDGFRA | 0.23679657 |
| 109 | INSR | 0.22577614 |
| 110 | PDK1 | 0.22564721 |
| 111 | RPS6KA6 | 0.21554401 |
| 112 | RPS6KA1 | 0.21453802 |
| 113 | PDPK1 | 0.20998383 |
| 114 | KSR2 | 0.20973097 |
| 115 | STK3 | 0.19993174 |
| 116 | TNK2 | 0.19255266 |
| 117 | GSK3A | 0.18764100 |
| 118 | PDGFRB | 0.18741160 |
| 119 | MAPK4 | 0.18078421 |
| 120 | MAP3K8 | 0.16917955 |
| 121 | SIK2 | 0.16366884 |
| 122 | CAMK1D | 0.15192586 |
| 123 | MAPK15 | 0.14795905 |
| 124 | CDK6 | 0.13712761 |
| 125 | PRKCH | 0.12839349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.21283758 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.55834901 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21516586 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 3.06047978 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.87512287 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.82423735 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.80139955 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.75712528 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72764582 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.71832609 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57553840 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.54703451 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51491206 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.43955935 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38447513 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.36337737 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.18625091 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.08022297 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.03903651 |
| 20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.99126297 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.96945142 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.91234847 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84718892 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.71710540 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.66568179 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63154839 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57652003 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.56755681 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51502266 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35099376 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31853856 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31771855 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26469852 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25655355 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.19776856 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18909800 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.18071209 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14378662 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11634715 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08883121 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05668676 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03934393 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.98217391 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.95719309 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 0.95422918 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90159488 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.87212555 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85544910 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85291663 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84718105 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.82555368 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81707202 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80792431 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80309272 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74505635 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71970915 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68620801 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64019690 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61197381 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54862789 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51895966 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48040116 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.46002622 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45899310 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.44571944 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44369931 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43147499 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43127405 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43112220 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39048895 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39047629 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36821030 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36232375 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34859956 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33724865 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33650428 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33558712 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31820640 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31240543 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28963834 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27294484 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26710363 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26656752 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26113895 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25345996 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21853593 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21421306 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.20743278 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19883457 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19471923 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18410149 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18140957 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16621317 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.16190527 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15546833 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15543890 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15292830 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14087239 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12835250 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11137207 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09764484 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09752029 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.09096003 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.09080402 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09036860 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.07011037 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04657950 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02558339 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02388080 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02297158 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.02067599 |

